{"hands_on_practices": [{"introduction": "Before designing a trial with a composite endpoint, we must be able to predict the overall event rate. This foundational exercise grounds your understanding in basic probability theory, demonstrating how to calculate the probability of a composite event from its individual components under the simplifying assumption of independence [@problem_id:5001500]. Mastering this calculation is the first step toward accurately powering a study and understanding the statistical benefits of using a composite endpoint.", "problem": "A Phase III randomized, double-blind clinical trial in cardiovascular translational medicine is designed with a composite endpoint consisting of non-fatal myocardial infarction and non-fatal ischemic stroke within one year. Composite endpoints are often used to increase statistical efficiency by aggregating multiple clinically meaningful events, but they require clear operational definitions. Let the component event indicators for myocardial infarction and stroke be independent Bernoulli random variables per patient, with probabilities $p_1$ and $p_2$, respectively. Independence is assumed for the purpose of this calculation; in practice, dependence is a potential pitfall that can bias the composite rate.\n\nStarting from the axioms of probability and the definition of the probability of a union of events, derive the probability of experiencing at least one component event under the independence assumption. Then, compute the composite event rate for $p_1=0.10$ and $p_2=0.15$. Finally, using the definition of the expected value for a sum of independent and identically distributed Bernoulli random variables in one trial arm, estimate the expected number of composite endpoint events in a single arm with $N=1000$ participants.\n\nExpress the composite event rate as a decimal and the expected number of events as a count. Provide exact values; do not round. Give your final answers as a row matrix $\\begin{pmatrix}\\text{composite rate} & \\text{expected events per arm}\\end{pmatrix}$ with no units inside the matrix.", "solution": "The problem presented is scientifically grounded, well-posed, and contains all necessary information for a complete solution. It requests the derivation and calculation of a composite event rate and the expected number of events in a clinical trial, based on fundamental principles of probability theory.\n\nLet $E_1$ be the event of a patient experiencing a non-fatal myocardial infarction and $E_2$ be the event of a patient experiencing a non-fatal ischemic stroke. The problem provides the probabilities of these events as $P(E_1) = p_1$ and $P(E_2) = p_2$. These events are modeled as independent Bernoulli random variables for each patient.\n\nThe composite endpoint event, which we shall denote as $E_C$, occurs if at least one of the component events occurs. This corresponds to the union of the events $E_1$ and $E_2$. The probability of the composite event is therefore $P(E_C) = P(E_1 \\cup E_2)$.\n\nAccording to the inclusion-exclusion principle for the probability of a union of two events, we have:\n$$P(E_1 \\cup E_2) = P(E_1) + P(E_2) - P(E_1 \\cap E_2)$$\nwhere $P(E_1 \\cap E_2)$ is the probability that both events occur.\n\nThe problem explicitly states that the component events $E_1$ and $E_2$ are to be considered independent. By definition of independence, the probability of the intersection of two events is the product of their individual probabilities:\n$$P(E_1 \\cap E_2) = P(E_1) \\times P(E_2) = p_1 p_2$$\n\nSubstituting this result into the inclusion-exclusion formula gives the derived probability of the composite event, which we denote as $p_C$:\n$$p_C = P(E_C) = p_1 + p_2 - p_1 p_2$$\n\nThe first task is to compute this composite event rate using the given values $p_1 = 0.10$ and $p_2 = 0.15$.\n$$p_C = 0.10 + 0.15 - (0.10)(0.15)$$\n$$p_C = 0.25 - 0.015$$\n$$p_C = 0.235$$\nThis is the composite event rate.\n\nThe second task is to estimate the expected number of composite endpoint events in a single trial arm with $N = 1000$ participants. Let $X_i$ be an indicator random variable for the $i$-th patient, where $i$ ranges from $1$ to $N$. We define $X_i = 1$ if the $i$-th patient experiences the composite event $E_C$, and $X_i = 0$ otherwise.\n\nGiven that the composite event occurs with probability $p_C$, each $X_i$ is a Bernoulli random variable with parameter $p_C$. The probability mass function is $P(X_i=1) = p_C$ and $P(X_i=0) = 1 - p_C$. The expected value of a single such Bernoulli random variable is:\n$$E[X_i] = (1 \\times P(X_i=1)) + (0 \\times P(X_i=0)) = p_C$$\n\nThe total number of composite events in the arm is the sum of these individual indicator variables: $S_N = \\sum_{i=1}^{N} X_i$. We need to find the expected value of this sum, $E[S_N]$.\n\nBy the linearity of expectation, the expectation of a sum of random variables is the sum of their individual expectations. This property holds regardless of whether the variables are independent.\n$$E[S_N] = E\\left[\\sum_{i=1}^{N} X_i\\right] = \\sum_{i=1}^{N} E[X_i]$$\n\nSince the patients are treated as independent and identically distributed (i.i.d.) trials, the expectation for each patient's indicator variable is the same: $E[X_i] = p_C$ for all $i = 1, \\dots, N$. Therefore, the sum simplifies to:\n$$E[S_N] = \\sum_{i=1}^{N} p_C = N p_C$$\n\nNow we substitute the numerical values $N=1000$ and $p_C = 0.235$ to find the expected number of events:\n$$E[S_N] = 1000 \\times 0.235 = 235$$\n\nThe expected number of composite endpoint events in the trial arm is $235$.\n\nThe final answer requires a row matrix containing the composite event rate and the expected number of events per arm. These values are $0.235$ and $235$, respectively.", "answer": "$$\\boxed{\\begin{pmatrix} 0.235 & 235 \\end{pmatrix}}$$", "id": "5001500"}, {"introduction": "One of the most significant pitfalls of composite endpoints is the potential for a common, less severe event to dominate the overall result, possibly obscuring a lack of effect on more critical outcomes like mortality. This practice challenges you to derive and analyze the mathematical conditions under which such dominance occurs [@problem_id:5001505]. By dissecting the relationship between baseline risk and treatment effect size, you will develop the critical intuition needed to question and interpret composite results thoughtfully.", "problem": "A translational medicine team designs a randomized controlled trial (RCT) to evaluate a new anti-inflammatory therapy in chronic cardiopulmonary disease. The primary endpoint is a composite defined as the time-to-first occurrence of either a non-life-threatening exacerbation requiring hospitalization (mild component, denoted $M$) or cardiovascular death (severe component, denoted $S$). The trial randomizes $N$ participants per arm, with identical follow-up and ascertainment procedures. For interpretability, the endpoint is analyzed as a binary risk over a fixed follow-up horizon.\n\nAssume the following foundational elements:\n- The risk (probability) of a component event in the control arm is $p_{Mc}$ for $M$ and $p_{Sc}$ for $S$.\n- The risk in the treatment arm is $p_{Mt}$ for $M$ and $p_{St}$ for $S$.\n- The risk ratio for each component is defined as $RR_M = p_{Mt}/p_{Mc}$ and $RR_S = p_{St}/p_{Sc}$.\n- Events are adjudicated as time-to-first occurrence, and the joint probability of experiencing both $M$ and $S$ within follow-up is negligible relative to the marginal event probabilities. The components can be treated as independent for the purpose of approximating the composite risk.\n- The composite endpoint occurs if $M$ or $S$ occurs within follow-up.\n\nStarting strictly from these definitions and the probability axioms (e.g., the probability of a union of rare events), derive an approximate expression for the composite risk ratio $RR_C$ and the absolute risk difference $\\Delta_C$ between arms. Use these derivations to analyze the conditions under which the mild component $M$ dominates the statistical signal of the composite, meaning it is the primary driver of both the magnitude of the composite risk difference and the location of the composite risk ratio. For a concrete sense of scale, consider that $M$ is common and $S$ is rare, for example $p_{Mc} \\approx 0.20$ and $p_{Sc} \\approx 0.02$, while keeping the derivation symbolic.\n\nWhich option correctly characterizes the condition under which the mild component $M$ dominates the composite signal?\n\nA. $p_{Mc}\\,\\lvert RR_M - 1 \\rvert > p_{Sc}\\,\\lvert RR_S - 1 \\rvert$ under the rare-union approximation and independence.\n\nB. $RR_M > RR_S$ is sufficient for $M$ to dominate, irrespective of $p_{Mc}$ and $p_{Sc}$.\n\nC. $p_{Sc} \\ll p_{Mc}$ guarantees $M$ dominance, regardless of $RR_M$ and $RR_S$.\n\nD. The composite risk ratio $RR_C$ equals $\\dfrac{RR_M\\,p_{Mt} + RR_S\\,p_{St}}{p_{Mt} + p_{St}}$, so $M$ dominates when $\\dfrac{p_{Mt}}{p_{Mt} + p_{St}} \\approx 1$.\n\nE. $M$ can dominate only if $p_{St} = 0$ in the treatment arm (no severe events under treatment).", "solution": "## DERIVATION AND OPTION ANALYSIS\n\nLet $C$ denote the composite endpoint, which occurs if event $M$ or event $S$ occurs. The risk of the composite endpoint, $p_C$, is the probability of the union of the component events, $p_C = P(M \\cup S)$.\n\nThe problem states that the joint probability is negligible and refers to the approximation for the union of rare events. This means we can approximate the probability of the union as the sum of the individual probabilities:\n$$p_C = P(M \\cup S) \\approx P(M) + P(S)$$\nThis approximation is equivalent to assuming the events $M$ and $S$ are mutually exclusive, $P(M \\cap S) = 0$, which is a stronger, simplifying assumption than independence, but is explicitly suggested by the problem's phrasing.\n\nApplying this approximation to each arm of the trial:\n- Risk of composite in control arm: $p_{Cc} \\approx p_{Mc} + p_{Sc}$\n- Risk of composite in treatment arm: $p_{Ct} \\approx p_{Mt} + p_{St}$\n\n### Derivation of Composite Effect Measures\n\n**1. Absolute Risk Difference ($\\Delta_C$)**\nThe absolute risk difference for the composite endpoint is defined as $\\Delta_C = p_{Ct} - p_{Cc}$.\nUsing the approximation:\n$$\\Delta_C \\approx (p_{Mt} + p_{St}) - (p_{Mc} + p_{Sc})$$\nRearranging the terms:\n$$\\Delta_C \\approx (p_{Mt} - p_{Mc}) + (p_{St} - p_{Sc})$$\nLet $\\Delta_M = p_{Mt} - p_{Mc}$ and $\\Delta_S = p_{St} - p_{Sc}$ be the absolute risk differences for the individual components. Thus:\n$$\\Delta_C \\approx \\Delta_M + \\Delta_S$$\nWe can express $\\Delta_M$ and $\\Delta_S$ in terms of risk ratios:\n- $\\Delta_M = p_{Mt} - p_{Mc} = (RR_M \\cdot p_{Mc}) - p_{Mc} = p_{Mc}(RR_M - 1)$\n- $\\Delta_S = p_{St} - p_{Sc} = (RR_S \\cdot p_{Sc}) - p_{Sc} = p_{Sc}(RR_S - 1)$\nSo, the total absolute risk difference is approximately:\n$$\\Delta_C \\approx p_{Mc}(RR_M - 1) + p_{Sc}(RR_S - 1)$$\n\n**2. Composite Risk Ratio ($RR_C$)**\nThe composite risk ratio is defined as $RR_C = p_{Ct} / p_{Cc}$.\nUsing the approximation:\n$$RR_C \\approx \\frac{p_{Mt} + p_{St}}{p_{Mc} + p_{Sc}}$$\nSubstituting the definitions of the component risk ratios ($p_{Mt} = RR_M p_{Mc}$ and $p_{St} = RR_S p_{Sc}$):\n$$RR_C \\approx \\frac{RR_M p_{Mc} + RR_S p_{Sc}}{p_{Mc} + p_{Sc}}$$\nThis shows that $RR_C$ is a weighted average of the component risk ratios, $RR_M$ and $RR_S$, with weights $w_M = \\frac{p_{Mc}}{p_{Mc} + p_{Sc}}$ and $w_S = \\frac{p_{Sc}}{p_{Mc} + p_{Sc}}$.\n\n### Analysis of Dominance Condition\n\nThe problem states that component $M$ \"dominates\" if it is the primary driver of **both** the magnitude of $\\Delta_C$ and the location of $RR_C$.\n\n1.  **Dominance of $RR_C$ location:** For $M$ to be the primary driver of the location of $RR_C$, the value of $RR_C$ must be primarily determined by $RR_M$. This occurs when the weight $w_M$ is much larger than $w_S$.\n    $$w_M \\gg w_S \\implies \\frac{p_{Mc}}{p_{Mc} + p_{Sc}} \\gg \\frac{p_{Sc}}{p_{Mc} + p_{Sc}} \\implies p_{Mc} \\gg p_{Sc}$$\n    This condition is inherent to the problem's setup, which specifies $M$ as the \"mild\" (and implicitly, more common) component and $S$ as the \"severe\" (and implicitly, rarer) component. The provided example values, $p_{Mc} \\approx 0.20$ and $p_{Sc} \\approx 0.02$, satisfy this condition.\n\n2.  **Dominance of $\\Delta_C$ magnitude:** For $M$ to be the primary driver of the magnitude of $\\Delta_C$, the contribution from component $M$ to the total risk difference, $\\Delta_M$, must be larger in magnitude than the contribution from component $S$, $\\Delta_S$.\n    $$|\\Delta_M| > |\\Delta_S|$$\n    Substituting the expressions derived earlier:\n    $$|p_{Mc}(RR_M - 1)| > |p_{Sc}(RR_S - 1)|$$\n    This simplifies to:\n    $$p_{Mc} |RR_M - 1| > p_{Sc} |RR_S - 1|$$\n    This is the critical condition that determines which component's treatment effect contributes more to the overall absolute risk reduction or increase. It is not automatically satisfied even if $p_{Mc} \\gg p_{Sc}$, because a very large effect on the rare component (a large value of $|RR_S - 1|$) could outweigh a small effect on the common component (a small value of $|RR_M - 1|$).\n\nThe question asks for the condition under which $M$ dominates. Given that $p_{Mc} \\gg p_{Sc}$ is the contextual background for a mild/severe composite, the decisive condition is the one governing the magnitude of the effect.\n\n### Option-by-Option Analysis\n\n**A. $p_{Mc}\\,\\lvert RR_M - 1 \\rvert > p_{Sc}\\,\\lvert RR_S - 1 \\rvert$ under the rare-union approximation and independence.**\nThis expression is precisely the condition $|\\Delta_M| > |\\Delta_S|$, which formalizes the requirement that component $M$ is the primary driver of the magnitude of the composite absolute risk difference, $\\Delta_C$. The derivation is directly based on the problem's stated premises and approximations. This condition is the non-trivial part of the dominance definition.\n**Verdict: Correct**\n\n**B. $RR_M > RR_S$ is sufficient for $M$ to dominate, irrespective of $p_{Mc}$ and $p_{Sc}$.**\nThis is incorrect. The dominance of the effect depends on the absolute risk differences, which are products of the baseline risks ($p_{Mc}$, $p_{Sc}$) and the relative effects (related to $RR_M$, $RR_S$). For instance, let $p_{Mc} = 0.05$, $p_{Sc} = 0.10$, $RR_M = 0.9$, and $RR_S=0.8$. Here $RR_M > RR_S$ (assuming both are $<1$). However, $|\\Delta_M| = 0.05|0.9-1| = 0.005$, while $|\\Delta_S| = 0.10|0.8-1| = 0.020$. In this case, $|\\Delta_S| > |\\Delta_M|$, so component $S$ dominates the absolute effect, contradicting the claim.\n**Verdict: Incorrect**\n\n**C. $p_{Sc} \\ll p_{Mc}$ guarantees $M$ dominance, regardless of $RR_M$ and $RR_S$.**\nThis is incorrect. While $p_{Sc} \\ll p_{Mc}$ ensures $M$ dominates the *location of the risk ratio $RR_C$*, it does not guarantee dominance of the absolute risk difference $\\Delta_C$. A strong treatment effect on the rare component $S$ can overwhelm a weak effect on the common component $M$. For example, let $p_{Mc}=0.20$, $p_{Sc}=0.02$. If $RR_M=0.95$ (a weak effect) and $RR_S=0.3$ (a strong effect), then $|\\Delta_M|=0.20|0.95-1|=0.01$ and $|\\Delta_S|=0.02|0.3-1|=0.014$. Here, $|\\Delta_S| > |\\Delta_M|$, so $S$ dominates the absolute risk difference.\n**Verdict: Incorrect**\n\n**D. The composite risk ratio $RR_C$ equals $\\dfrac{RR_M\\,p_{Mt} + RR_S\\,p_{St}}{p_{Mt} + p_{St}}$, so $M$ dominates when $\\dfrac{p_{Mt}}{p_{Mt} + p_{St}} \\approx 1$.**\nThe formula provided for $RR_C$ is incorrect. The correct derivation gives $RR_C \\approx \\frac{RR_M p_{Mc} + RR_S p_{Sc}}{p_{Mc} + p_{Sc}}$. The expression in the option is a nonsensical mix of risk ratios and treatment-arm probabilities. For instance, the term $RR_M p_{Mt}$ is $(p_{Mt}/p_{Mc})p_{Mt}$, which lacks a clear interpretation. Since the premise of the option (the formula for $RR_C$) is false, the entire statement is invalid.\n**Verdict: Incorrect**\n\n**E. $M$ can dominate only if $p_{St} = 0$ in the treatment arm (no severe events under treatment).**\nThis is an incorrect \"only if\" condition. Dominance by $M$ does not require the complete elimination of severe events $S$ by the treatment. For example, let $p_{Mc}=0.20$, $p_{Sc}=0.02$, $RR_M=0.8$, and $RR_S=0.5$. In this case, $p_{St} = 0.5 \\times 0.02 = 0.01 \\ne 0$. The absolute risk differences are $|\\Delta_M|=0.20|0.8-1|=0.04$ and $|\\Delta_S|=0.02|0.5-1|=0.01$. Since $|\\Delta_M| > |\\Delta_S|$, component $M$ dominates, even though $p_{St}$ is not zero.\n**Verdict: Incorrect**", "answer": "$$\\boxed{A}$$", "id": "5001505"}, {"introduction": "A statistically significant result for a composite endpoint is often just the beginning of the story. The crucial next question is: what is driving this effect? This advanced practice introduces a formal method for decomposing a composite hazard ratio into its component parts, allowing you to quantitatively assess which endpoints are the primary drivers of the overall conclusion [@problem_id:5001522]. This exercise will equip you with the analytical tools to move beyond the top-line result and perform a more nuanced, insightful interpretation of clinical trial data.", "problem": "A randomized controlled trial (RCT) compares treatment versus control on a time-to-first-event composite endpoint with two mutually exclusive components: component $1$ is non-fatal hospitalization and component $2$ is cardiovascular death. Assume independent censoring, rare events, and that within each arm the cause-specific hazards are approximately constant over time. Use only standard definitions for hazards and cumulative incidence, and the fact that for mutually exclusive failure types the composite hazard at time $t$ equals the sum of cause-specific hazards at time $t$. The trial accrued approximately equal person-time in each arm: $P_{T} \\approx P_{C} \\approx 4000$ person-years. The observed counts are: in control, $E_{1C} = 320$ and $E_{2C} = 80$; in treatment, $E_{1T} = 288$ and $E_{2T} = 56$. Let $\\beta_{j}$ denote the log hazard ratio for component $j \\in \\{1,2\\}$, and let $\\beta_{\\mathrm{comp}}$ denote the log hazard ratio for the composite endpoint. Using first principles and large-sample Poisson approximations for rare events:\n(i) derive an approximation that expresses $\\beta_{\\mathrm{comp}}$ as a weighted average of $\\beta_{1}$ and $\\beta_{2}$ in terms of baseline (control) component hazards;\n(ii) compute the corresponding weights from the observed control data and use them to predict $\\exp(\\beta_{\\mathrm{comp}})$ from $\\beta_{1}$ and $\\beta_{2}$;\n(iii) compute Wald $Z$-statistics for each component and for the composite using the log rate ratio variance formula under independent Poisson counts, and assess whether any observed overall statistical significance at level $\\alpha = 0.05$ is primarily driven by a single component (justify your assessment quantitatively).\nWhich option best describes a correct decomposition method and the correct data-based conclusion for this trial?\n\nA. Use additivity of cause-specific hazards and proportional hazards to show $\\beta_{\\mathrm{comp}} \\approx \\sum_{j} \\pi_{j}\\,\\beta_{j}$ with weights $\\pi_{j} = \\lambda_{jC}/(\\lambda_{1C}+\\lambda_{2C})$; estimate $\\lambda_{jC}$ by $E_{jC}/P_{C}$, giving $\\pi_{1} = 0.8$ and $\\pi_{2} = 0.2$, and predict $\\exp(\\beta_{\\mathrm{comp}}) \\approx \\exp\\!\\big(0.8\\log(0.90) + 0.2\\log(0.70)\\big) \\approx 0.856$, close to the observed composite rate ratio $344/400 \\approx 0.86$. Compute Wald $Z$ for each component via $Z_{j} = \\hat{\\beta}_{j}/\\mathrm{SE}(\\hat{\\beta}_{j})$ with $\\mathrm{Var}(\\hat{\\beta}_{j}) \\approx 1/E_{jT} + 1/E_{jC}$, yielding $Z_{1} \\approx -1.30$, $Z_{2} \\approx -2.05$, and $Z_{\\mathrm{comp}} \\approx -2.05$. A leave-one-component-out check shows excluding component $2$ yields non-significance, whereas excluding component $1$ remains significant; thus overall significance is primarily driven by component $2$.\n\nB. Average hazard ratios arithmetically without weighting to decompose, so $\\exp(\\beta_{\\mathrm{comp}}) \\approx \\big(\\exp(\\beta_{1}) + \\exp(\\beta_{2})\\big)/2 = (0.90 + 0.70)/2 = 0.80$, implying both components contribute equally. Conclude that overall significance, if present, cannot be attributed to a single component because both have similar influence by construction.\n\nC. Weight component-specific log hazard ratios by treated-arm hazards, i.e., use $\\tilde{\\pi}_{j} = \\lambda_{jT}/(\\lambda_{1T}+\\lambda_{2T})$, which here gives $\\tilde{\\pi}_{1} \\approx 0.837$ and $\\tilde{\\pi}_{2} \\approx 0.163$, leading to a predicted composite hazard ratio near $0.864$. Because component $1$ has the larger treated weight, conclude the composite significance is predominantly driven by non-fatal hospitalization (component $1$).\n\nD. Use subdistribution hazards to decompose the composite into subdistribution hazard ratios for each component and argue that dominance is assessed by whichever subdistribution hazard ratio deviates most from $1$. Conclude that subdistribution modeling is the correct framework to quantify the drivers of a time-to-first-event composite endpoint and that no leave-one-out assessment is needed.", "solution": "The problem statement is evaluated as valid. It is scientifically grounded in the principles of biostatistics and clinical trial analysis, is well-posed with sufficient information to derive a unique solution, and is expressed in objective, precise language. All assumptions and definitions required for the solution are explicitly provided.\n\nThe tasks require: (i) deriving an approximation for the composite log hazard ratio, $\\beta_{\\mathrm{comp}}$, as a weighted average of component log hazard ratios $\\beta_{1}$ and $\\beta_{2}$; (ii) computing these weights and predicting the composite hazard ratio from the component effects; and (iii) calculating Wald $Z$-statistics to determine the driver of any observed statistical significance.\n\n### (i) Derivation of the Approximation for $\\beta_{\\mathrm{comp}}$\n\nLet $\\lambda_{j,C}(t)$ and $\\lambda_{j,T}(t)$ be the cause-specific hazard functions for component $j \\in \\{1,2\\}$ at time $t$ in the control (C) and treatment (T) arms, respectively. The problem states that the composite hazard is the sum of the cause-specific hazards for mutually exclusive components.\n$$ \\lambda_{\\mathrm{comp},C}(t) = \\lambda_{1,C}(t) + \\lambda_{2,C}(t) $$\n$$ \\lambda_{\\mathrm{comp},T}(t) = \\lambda_{1,T}(t) + \\lambda_{2,T}(t) $$\nThe proportional hazards model assumes that the hazard ratio for each component is constant over time. Let $\\exp(\\beta_{j})$ be the hazard ratio for component $j$.\n$$ \\lambda_{j,T}(t) = \\lambda_{j,C}(t) \\exp(\\beta_{j}) $$\nThe hazard ratio for the composite endpoint, $\\exp(\\beta_{\\mathrm{comp}})$, may not be constant over time if $\\beta_{1} \\neq \\beta_{2}$.\n$$ \\exp(\\beta_{\\mathrm{comp}}(t)) = \\frac{\\lambda_{\\mathrm{comp},T}(t)}{\\lambda_{\\mathrm{comp},C}(t)} = \\frac{\\lambda_{1,T}(t) + \\lambda_{2,T}(t)}{\\lambda_{1,C}(t) + \\lambda_{2,C}(t)} = \\frac{\\lambda_{1,C}(t)\\exp(\\beta_{1}) + \\lambda_{2,C}(t)\\exp(\\beta_{2})}{\\lambda_{1,C}(t) + \\lambda_{2,C}(t)} $$\nWe can rewrite this as a weighted average of the component hazard ratios:\n$$ \\exp(\\beta_{\\mathrm{comp}}(t)) = \\left(\\frac{\\lambda_{1,C}(t)}{\\lambda_{1,C}(t) + \\lambda_{2,C}(t)}\\right)\\exp(\\beta_{1}) + \\left(\\frac{\\lambda_{2,C}(t)}{\\lambda_{1,C}(t) + \\lambda_{2,C}(t)}\\right)\\exp(\\beta_{2}) $$\nLet $\\pi_{j}(t) = \\frac{\\lambda_{j,C}(t)}{\\sum_{k=1}^{2} \\lambda_{k,C}(t)}$ be the proportion of the baseline (control) composite hazard attributable to component $j$ at time $t$. Then:\n$$ \\exp(\\beta_{\\mathrm{comp}}(t)) = \\pi_{1}(t)\\exp(\\beta_{1}) + \\pi_{2}(t)\\exp(\\beta_{2}) $$\nThe problem states that cause-specific hazards are approximately constant, $\\lambda_{j,C}(t) \\approx \\lambda_{j,C}$. This implies the weights $\\pi_{j}$ and the composite hazard ratio $\\exp(\\beta_{\\mathrm{comp}})$ are also approximately constant.\n$$ \\exp(\\beta_{\\mathrm{comp}}) \\approx \\pi_{1}\\exp(\\beta_{1}) + \\pi_{2}\\exp(\\beta_{2}) \\quad \\text{where} \\quad \\pi_{j} = \\frac{\\lambda_{j,C}}{\\lambda_{1,C} + \\lambda_{2,C}} $$\nTo express $\\beta_{\\mathrm{comp}}$ as a weighted average of $\\beta_{1}$ and $\\beta_{2}$, we take the logarithm and use a first-order Taylor expansion around $\\beta_{j}=0$. For small treatment effects, $\\exp(x) \\approx 1+x$.\n$$ \\exp(\\beta_{\\mathrm{comp}}) \\approx \\pi_{1}(1+\\beta_{1}) + \\pi_{2}(1+\\beta_{2}) = (\\pi_{1}+\\pi_{2}) + \\pi_{1}\\beta_{1} + \\pi_{2}\\beta_{2} $$\nSince $\\pi_{1}+\\pi_{2}=1$, this simplifies to $\\exp(\\beta_{\\mathrm{comp}}) \\approx 1 + \\pi_{1}\\beta_{1} + \\pi_{2}\\beta_{2}$.\nAlso, for a small composite effect, $\\exp(\\beta_{\\mathrm{comp}}) \\approx 1 + \\beta_{\\mathrm{comp}}$. Combining these gives the desired linear approximation on the log-scale:\n$$ \\beta_{\\mathrm{comp}} \\approx \\pi_{1}\\beta_{1} + \\pi_{2}\\beta_{2} $$\nThis matches the formula presented in option A.\n\n### (ii) Computation of Weights and Prediction\n\nThe problem states to use a large-sample Poisson approximation for rare events, where the constant hazard rate $\\lambda$ is estimated by $E/P$, the ratio of total events to total person-time.\nGiven data: $P_{T} \\approx P_{C} \\approx 4000$ person-years.\nControl events: $E_{1C} = 320$, $E_{2C} = 80$.\nTreatment events: $E_{1T} = 288$, $E_{2T} = 56$.\n\nFirst, we estimate the baseline (control) cause-specific hazards:\n$$ \\hat{\\lambda}_{1C} = \\frac{E_{1C}}{P_{C}} = \\frac{320}{4000} = 0.08 \\text{ events per person-year} $$\n$$ \\hat{\\lambda}_{2C} = \\frac{E_{2C}}{P_{C}} = \\frac{80}{4000} = 0.02 \\text{ events per person-year} $$\nNext, we compute the weights $\\pi_{j}$ from these estimated baseline hazards:\n$$ \\hat{\\pi}_{1} = \\frac{\\hat{\\lambda}_{1C}}{\\hat{\\lambda}_{1C} + \\hat{\\lambda}_{2C}} = \\frac{0.08}{0.08 + 0.02} = \\frac{0.08}{0.10} = 0.8 $$\n$$ \\hat{\\pi}_{2} = \\frac{\\hat{\\lambda}_{2C}}{\\hat{\\lambda}_{1C} + \\hat{\\lambda}_{2C}} = \\frac{0.02}{0.08 + 0.02} = \\frac{0.02}{0.10} = 0.2 $$\nNow, we estimate the component-specific log hazard ratios, $\\beta_{j}$. The hazard ratio $HR_{j}$ is estimated by the rate ratio $RR_{j}$.\n$$ \\widehat{HR}_{1} = \\frac{\\hat{\\lambda}_{1T}}{\\hat{\\lambda}_{1C}} = \\frac{E_{1T}/P_{T}}{E_{1C}/P_{C}} = \\frac{288/4000}{320/4000} = \\frac{288}{320} = 0.90 \\implies \\hat{\\beta}_{1} = \\log(0.90) \\approx -0.10536 $$\n$$ \\widehat{HR}_{2} = \\frac{\\hat{\\lambda}_{2T}}{\\hat{\\lambda}_{2C}} = \\frac{E_{2T}/P_{T}}{E_{2C}/P_{C}} = \\frac{56/4000}{80/4000} = \\frac{56}{80} = 0.70 \\implies \\hat{\\beta}_{2} = \\log(0.70) \\approx -0.35667 $$\nUsing the derived approximation, we predict $\\exp(\\beta_{\\mathrm{comp}})$:\n$$ \\exp(\\beta_{\\mathrm{comp}}) \\approx \\exp(\\hat{\\pi}_{1}\\hat{\\beta}_{1} + \\hat{\\pi}_{2}\\hat{\\beta}_{2}) = \\exp(0.8 \\times \\log(0.90) + 0.2 \\times \\log(0.70)) $$\n$$ \\exp(0.8 \\times (-0.10536) + 0.2 \\times (-0.35667)) = \\exp(-0.08429 - 0.07133) = \\exp(-0.15562) \\approx 0.8559 $$\nThis predicted value is approximately $0.856$. For comparison, the observed composite hazard ratio is:\n$$ \\widehat{HR}_{\\mathrm{comp}} = \\frac{(E_{1T}+E_{2T})/P_{T}}{(E_{1C}+E_{2C})/P_{C}} = \\frac{(288+56)/4000}{(320+80)/4000} = \\frac{344}{400} = 0.86 $$\nThe prediction $0.856$ is very close to the observed value $0.86$.\n\n### (iii) Wald $Z$-statistics and Assessment of Significance Drivers\n\nThe Wald statistic is $Z = \\hat{\\beta} / \\mathrm{SE}(\\hat{\\beta})$, where $\\mathrm{SE}(\\hat{\\beta}) = \\sqrt{\\mathrm{Var}(\\hat{\\beta})}$. The problem specifies the variance formula for the log rate ratio from independent Poisson counts: $\\mathrm{Var}(\\hat{\\beta}) \\approx 1/E_{T} + 1/E_{C}$.\n\nFor component 1 (non-fatal hospitalization):\n- $\\hat{\\beta}_{1} \\approx -0.10536$\n- $\\mathrm{Var}(\\hat{\\beta}_{1}) \\approx \\frac{1}{E_{1T}} + \\frac{1}{E_{1C}} = \\frac{1}{288} + \\frac{1}{320} \\approx 0.003472 + 0.003125 = 0.006597$\n- $\\mathrm{SE}(\\hat{\\beta}_{1}) \\approx \\sqrt{0.006597} \\approx 0.08122$\n- $Z_{1} = \\frac{-0.10536}{0.08122} \\approx -1.30$\n\nFor component 2 (cardiovascular death):\n- $\\hat{\\beta}_{2} \\approx -0.35667$\n- $\\mathrm{Var}(\\hat{\\beta}_{2}) \\approx \\frac{1}{E_{2T}} + \\frac{1}{E_{2C}} = \\frac{1}{56} + \\frac{1}{80} \\approx 0.017857 + 0.0125 = 0.030357$\n- $\\mathrm{SE}(\\hat{\\beta}_{2}) \\approx \\sqrt{0.030357} \\approx 0.17423$\n- $Z_{2} = \\frac{-0.35667}{0.17423} \\approx -2.05$\n\nFor the composite endpoint:\n- Total events: $E_{\\mathrm{comp},T} = 344$, $E_{\\mathrm{comp},C} = 400$.\n- $\\hat{\\beta}_{\\mathrm{comp}} = \\log(344/400) = \\log(0.86) \\approx -0.15082$\n- $\\mathrm{Var}(\\hat{\\beta}_{\\mathrm{comp}}) \\approx \\frac{1}{E_{\\mathrm{comp},T}} + \\frac{1}{E_{\\mathrm{comp},C}} = \\frac{1}{344} + \\frac{1}{400} \\approx 0.002907 + 0.0025 = 0.005407$\n- $\\mathrm{SE}(\\hat{\\beta}_{\\mathrm{comp}}) \\approx \\sqrt{0.005407} \\approx 0.07353$\n- $Z_{\\mathrm{comp}} = \\frac{-0.15082}{0.07353} \\approx -2.05$\n\nFor a two-sided significance level of $\\alpha = 0.05$, the critical value for the $Z$-statistic is $z_{1-\\alpha/2} = z_{0.975} \\approx 1.96$. We test if $|Z| > 1.96$.\n- Component 1: $|Z_{1}| \\approx 1.30 < 1.96$. Not statistically significant.\n- Component 2: $|Z_{2}| \\approx 2.05 > 1.96$. Statistically significant.\n- Composite: $|Z_{\\mathrm{comp}}| \\approx 2.05 > 1.96$. Statistically significant.\n\nThe overall significance of the composite endpoint ($Z_{\\mathrm{comp}} \\approx -2.05$) is almost identical to the significance of component 2 ($Z_{2} \\approx -2.05$), while component 1 is not significant ($Z_{1} \\approx -1.30$). A \"leave-one-component-out\" analysis confirms this: if we exclude component 2, the remaining endpoint (component 1) is not significant. If we exclude component 1, the remaining endpoint (component 2) is significant. Therefore, the statistical significance of the treatment effect on the composite endpoint is primarily driven by its effect on component 2 (cardiovascular death).\n\n### Evaluation of Options\n\n**A. Use additivity of cause-specific hazards and proportional hazards to show $\\beta_{\\mathrm{comp}} \\approx \\sum_{j} \\pi_{j}\\,\\beta_{j}$ with weights $\\pi_{j} = \\lambda_{jC}/(\\lambda_{1C}+\\lambda_{2C})$; estimate $\\lambda_{jC}$ by $E_{jC}/P_{C}$, giving $\\pi_{1} = 0.8$ and $\\pi_{2} = 0.2$, and predict $\\exp(\\beta_{\\mathrm{comp}}) \\approx \\exp\\!\\big(0.8\\log(0.90) + 0.2\\log(0.70)\\big) \\approx 0.856$, close to the observed composite rate ratio $344/400 \\approx 0.86$. Compute Wald $Z$ for each component via $Z_{j} = \\hat{\\beta}_{j}/\\mathrm{SE}(\\hat{\\beta}_{j})$ with $\\mathrm{Var}(\\hat{\\beta}_{j}) \\approx 1/E_{jT} + 1/E_{jC}$, yielding $Z_{1} \\approx -1.30$, $Z_{2} \\approx -2.05$, and $Z_{\\mathrm{comp}} \\approx -2.05$. A leave-one-component-out check shows excluding component $2$ yields non-significance, whereas excluding component $1$ remains significant; thus overall significance is primarily driven by component $2$.**\nThis option correctly states the theoretical derivation, the weights, the numerical prediction, the Z-statistics, and the final interpretation based on a sound quantitative assessment. All calculations are consistent with our analysis.\n**Verdict: Correct.**\n\n**B. Average hazard ratios arithmetically without weighting to decompose, so $\\exp(\\beta_{\\mathrm{comp}}) \\approx \\big(\\exp(\\beta_{1}) + \\exp(\\beta_{2})\\big)/2 = (0.90 + 0.70)/2 = 0.80$, implying both components contribute equally. Conclude that overall significance, if present, cannot be attributed to a single component because both have similar influence by construction.**\nThis option uses an incorrect decomposition method. The contribution of each component to the composite hazard ratio is weighted by its proportion of the baseline hazard, not averaged arithmetically. The calculation gives $0.80$, which is a poor approximation of the observed $0.86$. The conclusion is flawed.\n**Verdict: Incorrect.**\n\n**C. Weight component-specific log hazard ratios by treated-arm hazards, i.e., use $\\tilde{\\pi}_{j} = \\lambda_{jT}/(\\lambda_{1T}+\\lambda_{2T})$, which here gives $\\tilde{\\pi}_{1} \\approx 0.837$ and $\\tilde{\\pi}_{2} \\approx 0.163$, leading to a predicted composite hazard ratio near $0.864$. Because component $1$ has the larger treated weight, conclude the composite significance is predominantly driven by non-fatal hospitalization (component $1$).**\nThis option uses a non-standard weighting scheme (by treatment-arm hazards). The standard decomposition is based on control-arm (baseline) hazards. More critically, the conclusion is fallacious: it incorrectly attributes the driving force of significance to the component with the largest weight, ignoring the magnitude and statistical significance of the component-specific treatment effect. Component 1 is not statistically significant.\n**Verdict: Incorrect.**\n\n**D. Use subdistribution hazards to decompose the composite into subdistribution hazard ratios for each component and argue that dominance is assessed by whichever subdistribution hazard ratio deviates most from $1$. Conclude that subdistribution modeling is the correct framework to quantify the drivers of a time-to-first-event composite endpoint and that no leave-one-out assessment is needed.**\nThis option introduces a different modeling framework (subdistribution hazards for competing risks) which is inconsistent with the problem setup based on cause-specific hazards. The premise of the problem states that the composite hazard is the sum of the cause-specific hazards, which is not true for subdistribution hazards. While subdistribution hazard models are a valid tool for competing risks, they are not what the problem specifies or requires.\n**Verdict: Incorrect.**\n\nBased on this analysis, Option A is the only one that presents a methodologically sound derivation, correct calculations, and a valid interpretation of the results as requested by the problem.", "answer": "$$\\boxed{A}$$", "id": "5001522"}]}